Log In
BCIQ
Print this Print this
 

OraDisc A, amlexanox

  Manage Alerts
Collapse Summary General Information
Company Uluru Inc.
DescriptionAmlexanox delivered with Atrix's OraDisc bioadhesive polymer technology
Molecular Target Unknown
Mechanism of ActionUnknown
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAphthous ulcers
Indication DetailsTreat canker sores
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today